Publications
5491 Results
- Journal / Conference
- J Clin Oncol. Feb 1;41(4):803-815
- Year
- 2023
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID36306483
- Study Number(s)
- CTSU/C80702
Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials
- Journal / Conference
- J Clin Oncol. Mar 1;41(7):1359-1369
- Year
- 2023
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID36260828
- PMC
- PMC9995105
- Study Number(s)
- CTSU/E2211
Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)
- Journal / Conference
- J Geriatr Oncol. Jul;14(6):101538
- Year
- 2023
- Research Committee(s)
- Leukemia
- PMID
- PMID37329769
- Study Number(s)
- CTSU/A041202
Geriatric Assessment measures are predictive of outcomes in chronic lymphocytic leukemia
- Journal / Conference
- ASPO Annual Meeting (March 12-14, 2023, San Diego, CA)
- Year
- 2023
- Research Committee(s)
- Palliative and End of Life Care
- Study Number(s)
- S1316
Ability to Eat among Cancer Patients Treated for Malignant Bowel Obstruction: A Secondary Analysis within SWOG S1316
- Journal / Conference
- St. Gallen International Breast Cancer Conference (March 15-18, 2023; St. Gallen, Switzerland), e-poster
- Year
- 2023
- Research Committee(s)
- Breast
[CTP] TROPION-Breast03: Datopotamab deruxtecan (Dato-DXd) with or without durvalumab vs investigator's choice of therapy (ICT) for triple-negative breast cancer (TNBC) with residual disease following neoadjuvant therapy
- Journal / Conference
- Haematologica. Apr 6. doi: 10.3324/haematol.2023.282733. Online ahead of print
- Year
- 2023
- Research Committee(s)
- Leukemia
- PMID
- PMID37021537
- PMC
- PMC Journal - In Process
- Study Number(s)
- S0106, S0112, SWOG-9031, SWOG-9333
Examining the impact of age on the prognostic value of ELN-2017 and ELN-2022 AML risk stratifications: A SWOG report
- Journal / Conference
- Blood Advances Jun 30;bloodadvances.2023010223. doi: 10.1182/bloodadvances.2023010223. Online ahead of print
- Year
- 2023
- Research Committee(s)
- Lymphoma
- PMID
- PMID37389844
- Study Number(s)
- CTSU/9177
Prognostic Factors for Adult Burkitt Lymphoma Patients Treated with Dose-Adjusted EPOCH-R
- Journal / Conference
- Clin Cancer Res Aug 2;CCR-23-0917. doi: 10.1158/1078-0432.CCR-23-0917. Online ahead of print, 2023
- Year
- 2023
- Research Committee(s)
- Leukemia
- PMID
- PMID: 37531248
The new NCI precision medicine Trials
- Journal / Conference
- Blood Adv. Oct 10;7(19):5941-5953
- Year
- 2023
- Research Committee(s)
- Leukemia
- PMID
- PMID37267439
- PMC
- PMC10562769
- Study Number(s)
- S0106
Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, ECOG analysis
- Journal / Conference
- J Thorac Cardiovasc Surg. Jul 18:S0022-5223(23)00612-8
- Year
- 2023
- Research Committee(s)
- Lung
- PMID
- PMID37473998
- PMC
- In Process at NIHMS NIHMS1919951